Brief: Symetryx Corporation Says On Sept 13, Sent An Email To Neubase Therapeutics Proposing Specific Company As Potential Merger Candidate
14/09/2023 12:22
Sept 14 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* SYMETRYX CORPORATION- ON SEPT 13, SENT AN EMAIL TO NEUBASE
THERAPEUTICS PROPOSING A SPECIFIC COMPANY AS A POTENTIAL MERGER
CANDIDATE
* SYMETRYX CORPORATION- IF NEUBASE THERAPEUTICS IS
INTERESTED,
WILL FACILITATE AN INTRODUCTION OF NEUBASE THERAPEUTICS TO
POTENTIAL MERGER CANDIDATE
* SYMETRYX CORPORATION- CONSIDERING NEUBASE THERAPEUTICS'
OFFER TO
CONSIDER ADDING A PERSON PROPOSED BY CO TO NEUBASE'S BOARD OF
DIRECTORS
Source text for Eikon: ID:
Further company coverage: NBSE.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet